Theresa W. Kim, MD
Clinical Associate Professor, Medicine
Biography
Theresa W. Kim, MD is Clinical Associate Professor at Chobanian and Avedisian School of Medicine and clinician-investigator in the Section of General Internal Medicine at Boston Medical Center. After completing research training in a NIH-funded fellowship, she joined the faculty of the Clinical Addiction Research Education (CARE) program at Boston Medical Center. In addition to board-certification in Addiction Medicine and Internal Medicine, she is accredited as a HIV Specialist by the American Academy of HIV Medicine. She has extensive experience providing HIV and shelter-based primary care as a staff member of the Boston HealthCare for the Homeless Program for over 20 years. She has published and received NIH-funding for her research on improving access to addiction care in medical settings for disadvantaged populations. This has included examining 1) the impact of housing instability, depression, and substance use on access to care for people with HIV infection; 2) defining and measuring the quality of medical care on addiction outcomes; and 3) screening and brief intervention for unhealthy alcohol and drug use in general medical settings. In addition to a health services focus, she has published in the area of medical comorbidities including falls and poor bone health (osteoporosis and vitamin D deficiency).
Other Positions
- Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine
Education
- Boston University School of Medicine, MD
- Boston University School of Public Health, MSc
- Boston University, BA
Publications
- Published on 4/1/2024
Kim TW, Bertholet N, Magane KM, Lloyd-Travaglini C, Winter MR, Samet JH, Erlandson KM, Stein MD, Bryant KJ, Saitz R, Heeren TC. Alcohol Consumption and Illicit Drug Use: Associations With Fall, Fracture, and Acute Health Care Utilization Among People With HIV Infection. J Acquir Immune Defic Syndr. 2024 Apr 01; 95(4):391-398. PMID: 38133581.
Read at: PubMed - Published on 3/30/2024
Gill SV, Shin D, Kim TW, Magane KM, Hereen T, Winter M, Helfrich C, Saitz R. A Fall Prevention Feasibility Trial for People With HIV and Alcohol Use. OTJR (Thorofare N J). 2024 Mar 30; 15394492241238956. PMID: 38554013.
Read at: PubMed - Published on 1/18/2024
Lucero MM, Palfai TP, Heeren TC, Stein MD, Kim TW, Saitz R. Heavy Alcohol Use and HIV Outcomes: The Moderating Role of Pain. AIDS Behav. 2024 Feb; 28(2):636-644. PMID: 38236321.
Read at: PubMed - Published on 11/1/2023
Stein MD, Godersky ME, Kim TW, Walley AY, Heeren TC, Winter MR, Magane KM, Saitz R. Self-medication of pain and discomfort with alcohol and other substances by people with HIV infection and substance use disorder: preliminary findings from a secondary analysis. AIDS Care. 2024 Mar; 36(3):414-424. PMID: 37909062.
Read at: PubMed - Published on 6/27/2023
Bhatraju EP, Radick AC, Leroux BG, Kim TW, Samet JH, Tsui JI. Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder. Am J Drug Alcohol Abuse. 2023 Jul 04; 49(4):511-518. PMID: 37369019.
Read at: PubMed - Published on 5/18/2023
Klepp TD, Heeren TC, Winter MR, Lloyd-Travaglini CA, Magane KM, Romero-RodrÃguez E, Kim TW, Walley AY, Mason T, Saitz R. Cannabis use frequency and pain interference among people with HIV. AIDS Care. 2023 Aug; 35(8):1235-1242. PMID: 37201209.
Read at: PubMed - Published on 2/17/2023
Bertholet N, Saitz R, Hahn JA, Heeren TC, Emenyonu NI, Freiberg M, Winter MR, Kim TW, Magane KM, Lloyd-Travaglini C, Fatch R, Bryant K, Forman LS, Rateau L, Blokhina E, Muyindike WR, Gnatienko N, Samet JH. Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV. Alcohol Clin Exp Res. 2023 Apr; 47(4):704-712. PMID: 36799302.
Read at: PubMed - Published on 1/6/2023
Kratina-Hathaway Z, Radick AC, Leroux BG, Blalock K, Kim TW, Darnton J, Saxon AJ, Samet JH, Tsui JI. Methamphetamine use and illicit opioid use during buprenorphine treatment. J Subst Use Addict Treat. 2023 Aug; 151. PMID: 37811395.
Read at: PubMed - Published on 12/23/2022
Shin D, Gill SV, Kim TW, Magane KM, Mason T, Heeren T, Winter M, Helfrich C, Saitz R. Study Protocol for a Pilot Randomized Trial of a Virtual Occupational Therapy Fall Prevention Intervention for People With HIV and Alcohol Use. Subst Abuse. 2022; 16:11782218221145548. PMID: 36578450.
Read at: PubMed - Published on 10/25/2022
Radick AC, James J, Leroux BG, Kim TW, Saxon AJ, Samet JH, Tsui JI. Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting. J Addict Med. 2023 May-Jun 01; 17(3):300-304. PMID: 37267172.
Read at: PubMed
View 34 more publications: View full profile at BUMC